Human intelligence enhanced by artificial intelligence
A revolution in cardiovascular identification and management
How are you reducing heart failure readmissions?
How are you managing your cardiovascular patient population?
How do you know if a structural heart patient has been missed?
How are you reducing heart failure readmissions?
How are you managing your cardiovascular patient population?
How do you know if a structural heart patient has been missed?
Human intelligence enhanced by artificial intelligence
A revolution in cardiovascular identification and management
The Solution 
Improving Outcomes
This leading-edge solution delivers actionable insights through intuitive digital-health platforms, proprietary A.I. powered analytics and deep clinical expertise to help leading systems elevate the standard of patient care.
The Leading Cardiovascular Platform Has Expanded into Atrial Fibrillation:
Aortic
Stenosis
Mitral
Stenosis
Tricuspid
Regurgitation
Heart
Failure
Aortic
Regurgitation
Mitral
Regurgitation
Atrial
Fibrillation
Aortic
Stenosis
Mitral
Stenosis
Tricuspid
Regurgitation
Heart
Failure
Aortic
Regurgitation
Mitral
Regurgitation
Atrial
Fibrillation
Aortic
Stenosis
Aortic
Regurgitation
Mitral
Stenosis
Mitral
Regurgitation
Tricuspid
Regurgitation
Heart
Failure
Atrial
Fibrillation
The Challenge
Taking on the Challenge
CardioCare is a digital-health platform to help hospitals manage cardiovascular patients by focusing on:
Reducing Morbidity
& Mortality
Help physicians identify patients early to help prevent death, stroke & hospitalizations
Increasing Guideline-Directed Therapy
Increase appriopriate referrals to CV specialists
Standardizing
Quality
Understand variability in the care pathway from echo exams to referral patterns
The Solution
Improving Outcomes
This leading-edge solution delivers actionable insights through intuitive digital-health platforms, proprietary A.I. powered analytics and deep clinical expertise to help leading systems elevate the standard of patient care.
How it Works
Artificial Intelligence Solutions Elevating the Standard of Care Across the Cardiovascular Service Line
The CardioCare platform is a single-source solution that leverages artificial intelligence and big data analytics, helping hospital systems prioritize resources to identify patients who would benefit from guideline-directed therapy.
Big
Data
Leveraging AI from millions of records to help you understand your hospital's entire cardiovascular population
Insights
On Demand
Prioritizing care for patients eligible for life saving treatment
Artificial Intelligence Algorithms
Helping physicians identify patients with a higher likelihood of having undiagnosed severe disease
* The CardioCare platform is not intended for use in the diagnosis, cure, mitigation, treatment or prevention of cardiovascular diseases.
Testimonials
Leading hospitals partner with egnite’s CardioCare platform to reduce variability in care and improve guideline-directed therapy for patients with cardiovascular disease.
Swedish Medical Center
Director of Structural Interventions, Stanford Health Care
Resources
egnite, Inc. and JenaValve Announce Novel Research on Outcomes with Untreated Aortic Regurgitation at the 2024 American College of Cardiology Conference
egnite, Inc., a leading digital health company specializing in cardiovascular care, today announced the addition of two distinguished physicians, Vinod H. Thourani, MD and Nicholas Amoroso, MD to its Medical Advisory Board. Their wealth of expertise in cardiovascular care and dedication to innovation will significantly contribute to egnite’s mission to improve cardiovascular patient care nationwide.
Mortality Burden for Patients with Untreated Aortic Regurgitation
“This research underscores the poor outcomes for patients with moderate AR who exhibit cardiac damage, stressing the need to monitor for distinct characteristics in this population. These insights may also prompt a reassessment of our management strategies and suggest a shift in our approach to intensified follow-up for both moderate and severe AR patients.” Philippe Généreux, […]
egnite, Inc. Announces the Appointment of Vinod Thourani and Nicholas Amoroso to Its Medical Advisory Board
egnite, Inc., a leading digital health company specializing in cardiovascular care, today announced the addition of two distinguished physicians, Vinod H. Thourani, MD and Nicholas Amoroso, MD to its Medical Advisory Board. Their wealth of expertise in cardiovascular care and dedication to innovation will significantly contribute to egnite’s mission to improve cardiovascular patient care nationwide.